[EN] ARYLOXY AND ARYLALKYLENEOXY SUBSTITUTED IMIDAZOQUINOLINES<br/>[FR] IMIDAZOQUINOLINES SUBSTITUEES PAR ARYLOXY ET ARYLALKYLENEOXY
申请人:3M INNOVATIVE PROPERTIES CO
公开号:WO2005020999A1
公开(公告)日:2005-03-10
Imidazoquinoline compounds with an aryloxy or arylalkyleneoxy or hydroxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, and methods of use of these compounds as immunomodulators, for modulating cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.
A pyridine derivative represented by formula (I): ##STR1## wherein the symbols are as defined in the specification, which exhibits selective, potential, and long-lasting inhibitory activity on biosynthesis of thromboxane A.sub.2 and is useful in the treatment and prevention of a broad range of diseases.
The present invention relates to a detergent composition in aqueous solution comprising: (i) a surfactant selected from anionic, nonionic, zwitterionic and cationic surfactants and mixtures thereof, (ii) a precursor compound capable of giving rise to a peroxygen compound in the presence of water, (iii) a bleach activator capable of enhancing the bleaching activity of the peroxygen compound so formed, (iv) a suds suppressing agent and (v) a detergent building, characterised in that the bleach activator comprises one or more cyclic tertiary nitrogen compounds of a defined generic formula, said activator being at least partially soluble in water. The claimed bleach activators show bleaching activity at relatively low temperatures.
Aryloxy and Arylalkyleneoxy Substituted Imidazoquinolines
申请人:Lindstrom Kyle J.
公开号:US20090018122A1
公开(公告)日:2009-01-15
Imidazoquinoline compounds with an aryloxy or arylalkyleneoxy or hydroxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, and methods of use of these compounds as immunomodulators, for modulating cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.
ARYLOXY AND ARYLALKYLENEOXY SUBSTITUTED IMIDAZOQUINOLINES
申请人:LINDSTROM Kyle J.
公开号:US20110144099A1
公开(公告)日:2011-06-16
Imidazoquinoline compounds with an aryloxy or arylalkyleneoxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, and methods of use of these compounds as immunomodulators, for modulating cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.